Wonbiogen Balance Sheet Health
Financial Health criteria checks 5/6
Wonbiogen has a total shareholder equity of ₩32.6B and total debt of ₩6.8B, which brings its debt-to-equity ratio to 20.8%. Its total assets and total liabilities are ₩42.9B and ₩10.3B respectively. Wonbiogen's EBIT is ₩7.0B making its interest coverage ratio -43.2. It has cash and short-term investments of ₩8.6B.
Key information
20.8%
Debt to equity ratio
₩6.78b
Debt
Interest coverage ratio | -43.2x |
Cash | ₩8.56b |
Equity | ₩32.62b |
Total liabilities | ₩10.28b |
Total assets | ₩42.90b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A307280's short term assets (₩21.1B) exceed its short term liabilities (₩9.3B).
Long Term Liabilities: A307280's short term assets (₩21.1B) exceed its long term liabilities (₩931.4M).
Debt to Equity History and Analysis
Debt Level: A307280 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A307280's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A307280's debt is well covered by operating cash flow (71.4%).
Interest Coverage: A307280 earns more interest than it pays, so coverage of interest payments is not a concern.